Anandamide centrally depresses the respiratory rhythm generator of neonatal mice

Neuroscience

Volumn 170, Issue 4, 2010, Pages 1098-1109

  Tree, K ^a   Caravagna, C ^a   Hilaire, G ^a   Peyronnet, J ^a   Cayetanot, F ^a  

^a University of Mediterranée   (France)

Author keywords

Catecholamine; Endocannabinoid; In vitro; Neonate; Respiratory rhythm generator

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; PRAZOSIN; TYROSINE 3 MONOOXYGENASE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING; CATECHOLAMINE NERVE CELL; CATECHOLAMINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MEDULLA OBLONGATA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY RHYTHM GENERATOR; SPINAL CORD;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; MEDULLA OBLONGATA; MICE; PERIODICITY; POLYUNSATURATED ALKAMIDES; PRAZOSIN; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RESPIRATORY CENTER; YOHIMBINE;

EID: 77957137707     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.08.045     Document Type: Article

References (55)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 2002, 68:247-286.
2. Berrendero F., García-Gil L., Hernández M.L., Romero J., Cebeira M., de Miguel R., Ramos J.A., Fernández-Ruiz J.J. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 1998, 125:3179-3188.
3. Bongianni F., Mutolo D., Cinelli E., Pantaleo T. Respiratory responses induced by blockade of GABA and glycine receptors within the Bötzinger complex and the pre-Bötzinger complex of the rabbit. Brain Res 2010, 1344:134-147.
4. Brockhaus J., Ballanyi K. Synaptic inhibition in the isolated respiratory network of neonatal rats. Eur J Neurosci 1998, 10:3823-3839.
5. Carley D.W., Pavlovic M.D., Janelidze M., Radulovacki M. Functional role for cannabinoids in respiratory stability during sleep. Sleep 2002, 25:391-398.
6. Cayetanot F., Bodineau L., Frugière A. 5-HT acting on 5-HT1/2 receptors does not participate in the in vitro hypoxic respiratory depression. Neurosci Res 2001, 41:71-78.
7. Corcoran A.E., Milsom W.K. Maturational changes in pontine and medullary alpha-adrenoceptor influences on respiratory rhythm generation in neonatal rats. Respir Physiol Neurobiol 2009, 165:195-201.
8. Cristino L., De Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid tpye 1 receptors in the mouse brain. Neuroscience 2006, 139:1405-1415.
9. Del Negro C.A., Kam K., Hayes J.A., Feldman J.L. Asymetric control of inspiratory and expiratory phases by excitability in the respiratory network of neonatal mice in vitro. J Physiol 2009, 587:1217-1231.
10. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 1998, 21:521-528.
11. Di Pasquale E., Monteau R., Hilaire G., Iscoe S. Effects of ethanol on respiratory activity in the neonatal rat brainstem-spinal cord preparation. Brain Res 1995, 695:271-274.
12. Feldman J.L., Del Negro C.A. Looking for inspiration: new perspectives on respiratory rhythm. Nat Rev Neurosci 2006, 7(3):232-242.
13. Feldman J.L., Smith J.C. Cellular mechanisms underlying modulation of breathing pattern in mammals. Ann N Y Acad Sci 1989, 563:114-130.
14. Fernandez-Ruiz J., Gomez M., Hernandez M., De Miguel R., Ramos J.A. Cannabinoids and gene expression during brain development. Neurotox Res 2004, 6:389-401.
15. Freund T.S.F., Katona I.N., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
16. Fride E. The endocannabinoid-CB1 receptor system in pre- and postnatal life. Eur J Pharmacol 2004, 500:289-297.
17. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 1997, 17:5327-5333.
18. Hampson A.J., Bornheim L.M., Scanziani M., Yost C.S., Gray A.T., Hansen B.M., Leonoudakis D.J., Bickler P.E. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 1998, 70:671-676.
19. Harkany T., Guzman M., Galve-Roperh I., Berghuis P., Devi L.A., Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 2007, 28:83-92.
20. Haynar A., Guyenet P.G. Alpha 2-adrenoceptor-mediated presynaptic inhibition in bulbospinal neurons of rostral ventrolateral medulla. Am J Physiol Heart Circ Physiol 1999, 277:H1069-H1080.
21. Hilaire G., Viemari J.C., Coulon P., Simonneau M., Bevengut M. Modulation of the respiratory rhythm generator by the pontine noradrenergic A5 and A6 groups in rodents. Respir Physiol Neurobiol 2004, 143:187-197.
22. Koda S., Takeda S., Onimaru H., Akada S., Sakamoto A. Cannabinoid suppressed bicuculline-induced convulsion without respiratory depression in the brainstem-spinal cord preparation from newborn rats. Biomed Res 2005, 26:241-247.
23. Lacroix I., Cabou C., Montastruc J.L., Damase-Michel C. Adverse drug reactions in pregnant women. Thérapie 2007, 62:455-460.
24. Lauckner J.E., Hille B., Mackie K. The cannabinoid agonist WIN55,2122 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci U S A 2005, 102:19144-19149.
25. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 2004, 68:1691-1698.
26. Lyman W.D., Sonett J.R., Brosnan C.F., Elkin R., Bornstein M.B. Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol 1989, 23:73-81.
27. Mato S., Del Olmo E., Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 2003, 17:1747-1754.
28. McLemore G., Cooper R.Z.B., Richardson K.A., Mason A.V., Marshall C., Northington F.J., Gauda E.B. Cannabinoid receptor expression in peripheral arterial chemoreceptors during postnatal development. J Appl Physiol 2004, 97:1486-1495.
29. Mironov S.L. Metabotropic glutamate receptors activate dendritic calcium waves and TRPM channels which drive rhythmic respiratory patterns in mice. J Physiol 2008, 586:2277-2291.
30. Monteau R., Morin D., Hilaire G. Acetylcholine and central chemosensitivity: in vitro study in the newborn rat. Respir Physiol 1990, 81:241-253.
31. Müller-Vahl K.R., Schneider U., Koblenz A., Jöbges M., Kolbe H., Daldrup T., Emrich H.M. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry 2002, 35:57-61.
32. Oropeza V.C., Page M.E., van Bockstaele E.J. Systemic administration of WIN 55,2122 increases norepinephrine release in the rat frontal cortex. Brain Res 2005, 1046:45-54.
33. Ostrea E.M., Ostrea A.R., Simpson P.M. Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Pediatrics 1997, 100:79-83.
34. Padley J.R., Li Q., Pilowsky P.M., Goodchild A.K. Cannabinoid receptor in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats. Br J Pharmacol 2003, 140:384-394.
35. Page M.E., Oropeza V.C., van Bockstaele E.J. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex. Neurosci Lett 2008, 431:1-5.
36. Papay R., Gaivin R., Jha A., McCune D.F., McGrath J.C., Rodrigo M.C., Simpson P.C., Doze V.A., Perez D.M. Localization of the mouse alpha 1A adrenergic receptor (AR) in the brain: alpha 1A AR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J Comp Neurol 2006, 497:209-222.
37. Pfitzer T., Niederhoffer N., Szabo B. Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats. Br J Pharmacol 2004, 142:943-952.
38. Ren J., Greer J.J. Modulation of respiratory rhythmogenesis by chloride-mediated conductances during the perinatal period. J Neurosci 2006, 26:3721-3730.
39. Rosin D.L., Zeng D., Stornetta R.L., Norton F.R., Riley T., Okusa M.D., Guyenet P.G., Lynch K.R. Immunohistochemical localization of alpha 2a adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neuroscience 1993, 56:139-155.
40. Schlicker E., Kathmann M. Modulation of transmitters release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001, 22:565-572.
41. Schliker E., Timm J., Zentner J., Göthert M. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1997, 356:583-589.
42. Schmid K., Niederhoffer N., Szabo B. Analysis of the respiratory effects of cannabinoids in rats. Naunyn Schmiedebergs Arch Pharmacol 2003, 368:301-308.
43. Shouman B., Fontaine R.H., Baud O., Schwendimann L., Keller M., Spedding M., Lelièvre V., Gressens P. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol 2006, 148:442-451.
44. Smith J.C., Ellenberger H.H., Ballanyi K., Richter D.W., Feldman J.L. Pre-bötzinger complex a brainstem region that may generate respiratory rhythm in mammals. Science 1991, 254:726-729.
45. Song Z.H., Slowey C.A., Hurst D.P., Reggio P.H. The difference between the CB1 and CB2 cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN552122 for CB2. Mol Pharmacol 1999, 56:834-840.
46. Sperlagh B., Windisch K., Ando R.D., Sylvester Vizi E. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens. Neurochem Int 2009, 54:452-457.
47. Suzue T. Respiratory rhythm generation in the in vitro brainstem-spinal cord preparation of the neonatal rat. J Physiol 1984, 354:173-183.
48. Szabo B., Schlicker E. Effects of cannabinoids on neurotransmission. Handb Exp Pharmacol 2005, 168:327-365.
49. Thoby-Brisson M., Greer J.J. Anatomical and functional development of the pre-Bötzinger complex in prenatal rodents. J Appl Physiol 2008, 104:1213-1219.
50. Thoby-Brisson M., Karlén M., Wu N., Charnay P., Champagnat J., Fortin G. Genetic identification of an embryonic parafacial oscillator coupling to the preBötzinger complex. Nat Neurosci 2009, 12:1028-1036.
51. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
52. Viemari J.C. Noradrenergic modulation of the respiratory neural network. Respir Physiol Neurobiol 2008, 164:123-130.
53. Viemari J.C., Hilaire G. Noradrenergic receptors and in vitro respiratory rhythm: possible interspecies differences between mouse and rat neonates. Neurosci Lett 2002, 294:149-153.
54. Wallen-Mackenzie A., Gezelius H., Thoby-Brisson M., Nygård A., Enjin A., Fujiyama F., Fortin G., Kullander K. Vesicular glutamate transporter 2 is required for central respiratory rhythm generation but not for locomotor central pattern generation. J Neurosci 2006, 26:12294-12307.
55. Zanella S., Roux J.C., Viemari J.C., Hilaire G. Possible modulation of the mouse respiratory rhythm generator by A1/C1 neurones. Respir Physiol Neurobiol 2006, 153:126-138.